Table 3:

Comparison of different inclusion criteria for lung cancer screening between 1998 and 2015 with a shift scenario (n = 8938)*

VariableUSPSTFCTFPHCQuebec pilot (55–74 yr + PLCOm2012 ≥ 2%)Quebec pilot (50–74 yr + PLCOm2012 ≥ 2%)PLCOm2012 ≥ 1.51%PLCOm2012 ≥ 1.7%PLCOm2012 ≥ 2.0%
Total no. of participants eligible to be screened, n (%) (n = 8938)4445 (49.7)2523 (28.2)1931 (21.6)2045 (22.9)2733 (30.6)2430 (27.2)2064 (23.1)
Total no. of LDCTs40448196971520116672247322102016777
No. of lung cancers detected, n (%) (n = 205)133 (64.9)101 (49.3)99 (48.3)103 (50.2)114 (55.6)110 (53.7)103 (50.2)
No. of LDCTs for 1 cancer detected304.1195.0153.5161.9216.9191.1162.9
No. of participants screened to detect 1 lung cancer33.425.019.519.924.022.120.0
No. of LDCTs before cancer detection per participant10.38.67.78.29.69.18.3
No. of LDCTs per cancer-free participant9.17.87.98.19.08.68.1
Sensitivity, % (95% CI)64.9 (57.9–71.4)49.3 (42.2–56.3)48.3 (41.3–55.4)50.2 (43.2–57.3)55.6 (48.5–62.5)53.7 (46.6–60.6)50.2 (43.2–57.3)
Specificity, % (95% CI)73.4% (73.2–73.7)87.1 (86.9–87.3)90.0 (89.9–90.2)89.1 (88.9–89.2)83.8 (83.6–84.0)86.2 (86.0–86.4)89.0 (88.9–89.2)
Positive predictive value, % (95% CI)3.0% (2.5–3.5)4.2 (3.5–5.0)5.1 (4.2–6.2)5.0 (4.1–6.1)4.2 (3.5– 5.0)4.5 (3.7–5.4)5.0 (4.1–6.0)
  • Note: CTFPHC = Canadian Task Force on Preventive Health Care, LDCT = low-dose computed tomography, USPSTF = United States Preventive Services Task Force.

  • * We checked eligibility annually. If a participant met the screening criteria, we considered that they had an LDCT on the screening date and an LDCT each year during the next 5 years. If a participant no longer met the screening criteria, they had to complete the remained LDCT.

  • Only participants with at least 1 LDCT.